Mediwound Ltd (MDWD)

07:20 AM

MediWound (NASDAQ:MDWD) shareholder returns have been respectable, earning 53% in 5 years - Simply Wall St

07:20 AM

Mar 12, 2025

MediWound (MDWD) Projected to Post Earnings on Wednesday - Defense World

Mar 12, 2025

Mar 11, 2025

MediWound Ltd. (NASDAQ:MDWD) Shares Acquired by Rhumbline Advisers - Defense World

Mar 11, 2025

Mar 10, 2025

Pollard Banknote Reports 4th Quarter and Annual Financial Results - The Globe and Mail

Mar 10, 2025

Mar 07, 2025

MediWound Ltd. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Mar 06, 2025

MediWound at TD Cowen Conference: Strategic Insights on Growth - Investing.com India

Mar 06, 2025

Mar 03, 2025

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Mar 03, 2025

Mar 03, 2025

When Will MediWound Reveal Its 2024 Financial Performance? Key Date Announced - StockTitan

Mar 03, 2025

Mar 03, 2025

MediWound (NASDAQ:MDWD) Research Coverage Started at Craig Hallum - Defense World

Mar 03, 2025

Mar 01, 2025

MediWound (NASDAQ:MDWD) Now Covered by Analysts at Craig Hallum - MarketBeat

Mar 01, 2025

Mar 01, 2025

Craig-Hallum sets $39 target on MediWound stock with buy rating - Investing.com Canada

Mar 01, 2025

Feb 28, 2025

(MDWD) Investment Report - Stock Traders Daily

Feb 28, 2025

Feb 28, 2025

This CoStar Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Feb 28, 2025

Feb 28, 2025

Craig-Hallum sets $39 target on MediWound stock with buy rating By Investing.com - Investing.com South Africa

Feb 28, 2025

Feb 28, 2025

Laurentian Bank of Canada declares dividend on its common shares - The Globe and Mail

Feb 28, 2025

Feb 26, 2025

Burns Pipeline 2024: Therapies, MOA Insights, and Key Clinical - openPR

Feb 26, 2025

Feb 25, 2025

MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care - GlobeNewswire

Feb 25, 2025

Feb 25, 2025

Can NexoBrid Transform Pediatric Burn Care? Phase III Results Show Superiority - StockTitan

Feb 25, 2025

Feb 24, 2025

MediWound to Present at the 45th Annual TD Cowen Health Care Conference - GlobeNewswire

Feb 24, 2025

Feb 24, 2025

Can MediWound's Tissue Repair Innovation Reshape the Healthcare Market? CEO Reveals Strategy - StockTitan

Feb 24, 2025

Feb 18, 2025

(MDWD) Trading Signals - Stock Traders Daily

Feb 18, 2025

Feb 15, 2025

MediWound stock climbs 4% on Phase 3 study initiation - MSN

Feb 15, 2025

Feb 13, 2025

MediWound begins pivotal Phase III trial for wound therapy By Investing.com - Investing.com Nigeria

Feb 13, 2025

Feb 12, 2025

MediWound begins pivotal Phase III trial for wound therapy - MSN

Feb 12, 2025

Feb 12, 2025

MediWound Launches Phase III Trial Evaluating EscharEx for Treating Venous Leg Ulcers - Marketscreener.com

Feb 12, 2025

Feb 12, 2025

Mediwound’s EscharEx Shows Promising Results in Phase 3 Trial - TipRanks

Feb 12, 2025

Feb 12, 2025

MediWound Launches Phase III Trial for EscharEx Targeting Venous Leg Ulcers - TipRanks

Feb 12, 2025

Feb 12, 2025

MediWound to launch Phase III trial for venous leg ulcers -February 12, 2025 at 07:00 am EST - Marketscreener.com

Feb 12, 2025

Feb 12, 2025

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers - GlobeNewswire

Feb 12, 2025

Feb 12, 2025

EscharEx Clinical Trial: MediWound's Groundbreaking Solution for $375M Venous Ulcer Market - StockTitan

Feb 12, 2025

Feb 12, 2025

Is MediWound (NASDAQ:MDWD) In A Good Position To Invest In Growth? - Simply Wall St

Feb 12, 2025

Feb 08, 2025

JPMorgan Chase & Co. Has $61,000 Stock Position in MediWound Ltd. (NASDAQ:MDWD) - MarketBeat

Feb 08, 2025

Feb 07, 2025

How the (MDWD) price action is used to our Advantage - Stock Traders Daily

Feb 07, 2025

Feb 04, 2025

MediWound to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - The Manila Times

Feb 04, 2025

Feb 04, 2025

Exclusive: MediWound CEO to Reveal Latest Tissue Repair Innovations at Major Healthcare Conference - StockTitan

Feb 04, 2025

Feb 04, 2025

JPMorgan Chase & Co. Sells 75,360 Shares of MediWound Ltd. (NASDAQ:MDWD) - Defense World

Feb 04, 2025

Jan 28, 2025

MediWound Ltd.'s (NASDAQ:MDWD) high institutional ownership speaks for itself as stock continues to impress, up 15% over last week - Yahoo Finance

Jan 28, 2025

Jan 27, 2025

MediWound (MDWD) Surges 8.5%: Is This an Indication of Further Gains? - Yahoo Finance

Jan 27, 2025

Jan 22, 2025

Barclays PLC Increases Stock Holdings in MediWound Ltd. (NASDAQ:MDWD) - Defense World

Jan 22, 2025

Jan 22, 2025

BioHarvest Sciences Strengthens Board with Healthcare Industry Veteran Sharon Malka - StockTitan

Jan 22, 2025

Jan 21, 2025

Burns Pipeline 2024: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight | MediWound, Kaken Pharma, Kerecis, Medline, Mallinckrodt Pharma, Avita Medical, Vericel Corp - The Globe and Mail

Jan 21, 2025

Jan 16, 2025

Trading (MDWD) With Integrated Risk Controls - Stock Traders Daily

Jan 16, 2025

Jan 12, 2025

HC Wainwright Reaffirms “Buy” Rating for MediWound (NASDAQ:MDWD) - Defense World

Jan 12, 2025

Jan 10, 2025

MediWound (NASDAQ:MDWD) Receives "Buy" Rating from HC Wainwright - MarketBeat

Jan 10, 2025

Jan 09, 2025

Mediwound Advances in Enzymatic Therapeutics with Strategic Expansions - Yahoo Finance

Jan 09, 2025

Jan 09, 2025

MediWound Ltd.'s (NASDAQ:MDWD) P/S Still Appears To Be Reasonable - Simply Wall St

Jan 09, 2025

Jan 09, 2025

Geode Capital Management LLC Sells 2,365 Shares of MediWound Ltd. (NASDAQ:MDWD) - Defense World

Jan 09, 2025

Jan 07, 2025

Barclays PLC Raises Stake in MediWound Ltd. (NASDAQ:MDWD) - Defense World

Jan 07, 2025